Frontlight ResearchEarly access
Trial site
Istituti Clinici Scientifici Maugeri In Forma Abbreviata Istituti Clinici Scientifici Maugeri O Anche Ics Maugeri O Maugeri S.p.A. Sb
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease3 trials
- Head and neck cancer2 trials
- IgA nephropathy2 trials
- Kidney cancer1 trial
- Metastatic breast cancer1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Ventricular tachycardia1 trial
- Phase
- Phase 38 trials
- Phase 23 trials
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting2 trials
- Lead sponsor
- AstraZeneca1 trial
- AVEO Pharmaceuticals, Inc.1 trial
- BeiGene1 trial
- BeOne Medicines1 trial
- Boehringer Ingelheim1 trial
- and 7 more
Running trials
Recruiting
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Head and neck cancer1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026